Contact Information for Reporting of Adverse Events

Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system or to the local partner. Patients are encouraged to call their healthcare provider if they have any concerns about Avibela and patients may also report any suspected adverse reactions via the national reporting system or to the local partner. Contact information for the national reporting systems and local partners can be found below.